Answer
Niraparib tosylate monohydrate inhibits PARP-1 and PARP-2, enzymes involved in DNA repair, and laboratory studies suggest its cytotoxicity may involve inhibition of PARP enzymatic activity and increased PARP–DNA complex formation, resulting in DNA damage, apoptosis and cell death.
Sources for this answer
- Zejula 100mg TabletsGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 9Document updated
Sources checked